GLP-1 drug slows aging in mice | National Institutes of Health (NIH)

These include reduced risks of cardiovascular, kidney, liver, and neurodegenerative diseases. But not all of these effects can be explained by weight …

Continue in Briflio to read, react, comment, and share.